Skip to main content
SciBX: Science-Business eXchange
As published Thursday, July 31, 2014

  • Cover Story: Fresh air for COPD

    By Benjamin Boettner, Associate Editor

    Fresh air for COPD

    An undisclosed company has picked up an integrin-targeting antibody from the University of California, San Francisco that could address the underlying pathology in chronic obstructive pulmonary disease by improving airway remodeling via suppressing transforming growth factor-b1.1 The home run will be whether the antibody reverses existing damage.

    Full Article


  • This Week in Therapeutics

    Inhibiting BET bromodomain proteins to promote remyelination in MS; inhibiting miR-130 and miR-301 to treat pulmonary hypertension; promoting vp30 phosphorylation to block Ebola virus infection; and more...

  • more therapeutics news
  • This Week in Techniques

    A microfluidic chip for cultivation of diverse bacterial species; a noninvasive MRI signature for predicting epilepsy; tantalum oxide nanoparticles for X-ray imaging of articular cartilage; and more...

  • more techniques news
Subscribe Now
Free Trial